CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

Overview Fund Activity
Delisted

CNCR was delisted on the 27th of May, 2025.

Back to rankings

23 hedge funds and large institutions have $12.5M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.

Holders
23
Holders Change
-5
Holders Change %
-17.86%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BL
1
BCWM LLC
Kansas
$4.5M
2
PAG
2
Private Advisor Group
New Jersey
$376K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$1.04M
4
OC
4
Oppenheimer & Co
New York
$201K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$716K

Top Sellers

1
Jane Street
1
Jane Street
New York
$203K
2
WCA
2
Waratah Capital Advisors
Ontario, Canada
$0
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$19K
4
PCM
4
Prelude Capital Management
New York
$0
5
Commonwealth Equity Services
5
Commonwealth Equity Services
Massachusetts
$359K
Name Holding Trade Value Shares
Change 		Shares
Change %
SPC
26
Sigma Planning Corp
Michigan
– -$232K -9,618 Closed
WAP
27
Wealthcare Advisory Partners
Pennsylvania
– -$39K -1,600 Closed
Toronto Dominion Bank
28
Toronto Dominion Bank
Ontario, Canada
– -$21K -858 Closed
GT
29
Glenmede Trust
Pennsylvania
– -$17K -700 Closed
CIBC Private Wealth Group
30
CIBC Private Wealth Group
Georgia
– -$12K -505 Closed
1
2